Bristol Myers Squibb logo

Latest headlines

Bristol Myers Squibb News

The latest Bristol Myers Squibb (BMY) news, aggregated as it breaks. News moves sentiment and sentiment moves price, so read these BMY headlines next to the live Bristol Myers Squibb Fear and Greed Index.

Latest Bristol Myers Squibb Headlines48

Bristol Myers Squibb Isn't Nearly as Cheap as It Looks -- Here's the 1 Thing That Could Change That

fool.com · Aug 1, 2026

BMY Q2 Earnings Call Highlights Growth Portfolio Momentum

zacks.com · Jul 31, 2026

Why Bristol Myers Squibb Stock Topped the Market on Thursday

fool.com · Jul 30, 2026

Bristol-Myers Squibb Company (BMY) Q2 2026 Earnings Call Transcript

seekingalpha.com · Jul 30, 2026

Bristol-Myers Boosts 2026 Guidance on Portfolio Strength

benzinga.com · Jul 30, 2026

BMY Q2 Earnings Beat Estimates, '26 View Raised, Stock Up

zacks.com · Jul 30, 2026

Bristol Myers Squibb: Upgrading To Buy On Positive Q2 Earnings, Long-Term Outlook

seekingalpha.com · Jul 30, 2026

Gold Surges 3%; Bristol-Myers Squibb Earnings Top Views

benzinga.com · Jul 30, 2026

Bristol Myers (BMY) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates

zacks.com · Jul 30, 2026

Bristol Myers Squibb (BMY) Q2 Earnings and Revenues Beat Estimates

zacks.com · Jul 30, 2026

Bristol-Myers Squibb: Why I'm Still Bullish After Q2

seekingalpha.com · Jul 30, 2026

Bristol Myers Lifts Outlook as Profit, Revenue Rise

wsj.com · Jul 30, 2026

Bristol Myers raises 2026 forecast as Eliquis, newer medicines power results

reuters.com · Jul 30, 2026

Bristol Myers Raises Earnings Guidance as Newer Drugs Drive Big Quarterly Beat

barrons.com · Jul 30, 2026

Bristol Myers Squibb Reports Second Quarter Financial Results for 2026

businesswire.com · Jul 30, 2026

How To Earn $500 A Month From Bristol-Myers Squibb Stock Ahead Of Q2 Earnings

benzinga.com · Jul 29, 2026

My 3 Favorite Artificial Intelligence (AI) Stocks to Buy Right Now

fool.com · Jul 28, 2026

Should You Buy, Hold, or Sell BMY Stock Ahead of Q2 Earnings?

zacks.com · Jul 27, 2026

Wall Street's Insights Into Key Metrics Ahead of Bristol Myers (BMY) Q2 Earnings

zacks.com · Jul 27, 2026

Buy 4 Barron's Better Bets (Than T-Bills) Out Of 11 'Safer' July DiviDogs

seekingalpha.com · Jul 26, 2026

Israel "Izzy" Englander Increased His Position in This Pharma Stock by 780%. Does He Know Something Wall Street Doesn't?

fool.com · Jul 26, 2026

Is Bristol Myers Squibb's Dividend Too Good to Be True? Here's My Honest Answer

fool.com · Jul 24, 2026

Why Investors Need to Take Advantage of These 2 Medical Stocks Now

zacks.com · Jul 24, 2026

Bristol Myers Squibb (BMY) Rises As Market Takes a Dip: Key Facts

zacks.com · Jul 23, 2026

Bristol Myers Squibb (BMY) Reports Next Week: Wall Street Expects Earnings Growth

zacks.com · Jul 23, 2026

Why Bristol Myers Squibb (BMY) is a Top Momentum Stock for the Long-Term

zacks.com · Jul 22, 2026

Bristol Myers buys Nvidia's latest AI computing system for drug research

reuters.com · Jul 20, 2026

Bristol Myers Squibb to Build the Most Powerful AI Factory in Life Sciences with NVIDIA

businesswire.com · Jul 20, 2026

Why the Market Dipped But Bristol Myers Squibb (BMY) Gained Today

zacks.com · Jul 16, 2026

Here's Why Bristol Myers Squibb (BMY) is a Strong Value Stock

zacks.com · Jul 16, 2026

Will Bristol Myers (BMY) Beat Estimates Again in Its Next Earnings Report?

zacks.com · Jul 15, 2026

Bristol Myers Squibb Company (BMY) is Attracting Investor Attention: Here is What You Should Know

zacks.com · Jul 15, 2026

Can BMY's CELMoD Program Advancements Strengthen Its Oncology Portfolio?

zacks.com · Jul 14, 2026

Donald Trump's Drug-Pricing Deals Are Reshaping Big Pharma -- Here's What That Means for Pfizer, AbbVie, and Bristol Myers Squibb

fool.com · Jul 14, 2026

Bristol Myers Squibb Moves Closer to New Multiple Myeloma Treatment

benzinga.com · Jul 13, 2026

U.S. Food and Drug Administration Accepts Bristol Myers Squibb's New Drug Application for Mezigdomide in Patients with Relapsed or Refractory Multiple Myeloma

businesswire.com · Jul 13, 2026

Start Investing At 60 And Retire On Dividends Forever

seekingalpha.com · Jul 10, 2026

2 Dirt Cheap Dividend Stocks to Buy With $1,000 Right Now

fool.com · Jul 7, 2026

3 High-Yield Dividend Stocks to Buy and Hold Forever (Hint: AbbVie Makes the List)

fool.com · Jul 7, 2026

Is Bristol Myers Squibb's 4.3% Dividend Yield Safe? Here's What Investors Need to Know.

fool.com · Jul 6, 2026

Bristol Myers Squibb: Pain First, Payoff Later?

seekingalpha.com · Jul 3, 2026

Bristol-Myers Squibb: Cash Flow Machine, Outsized Growth Portfolio, And Inflation Beating Incomes

seekingalpha.com · Jul 3, 2026

Bristol Myers Squibb Company (BMY) Is a Trending Stock: Facts to Know Before Betting on It

zacks.com · Jul 1, 2026

Bristol Myers Squibb vs. Johnson & Johnson: Which Healthcare Stock Is a Better Buy in 2026?

fool.com · Jul 1, 2026

Why Bristol Myers Squibb (BMY) is a Top Value Stock for the Long-Term

zacks.com · Jun 30, 2026

Merck, AbbVie probed by US lawmakers over China clinical trials: report

proactiveinvestors.com · Jun 30, 2026

Recursion Pharmaceuticals vs. Summit Therapeutics: Which Healthcare Stock Is a Better Buy in 2026?

fool.com · Jun 30, 2026

Bristol Myers Squibb (BMY) Exceeds Market Returns: Some Facts to Consider

zacks.com · Jun 29, 2026

Why Is Bristol Myers Squibb Up or Down Today?

When Bristol Myers Squibb (BMY) moves sharply, the reason is almost always in the headlines above. Earnings, guidance, analyst upgrades and downgrades, product news and macro data are the usual drivers of a BMY move on the day. The feed shows what broke and when, and the sentiment tag on each story shows whether the coverage skews positive or negative, so you can see at a glance why Bristol Myers Squibb is up or down today.

How Bristol Myers Squibb News Affects the Price

News does not move the Bristol Myers Squibb (BMY) price directly, it moves sentiment, and sentiment moves price. A run of negative headlines pulls the Bristol Myers Squibb Fear and Greed Index toward fear, while positive coverage pushes it toward greed, often before the price has fully reacted. A surprise story usually shows up first as a spike in Bristol Myers Squibb trading volume. That is the chain to watch: headline, sentiment, volume, then the BMY price.

Trade the Bristol Myers Squibb News With Sentiment

Headlines tell you what happened; the Fear and Greed Index tells you how the crowd is reacting. Watch Bristol Myers Squibb trading volume spike on a big story, check the Bristol Myers Squibb price history for context, follow the live BMY price, see the Bristol Myers Squibb price prediction, and read the Bristol Myers Squibb Fear and Greed Index for mood.

How do you feel about Bristol Myers Squibb?

1D

Frequently asked questions

Why is Bristol Myers Squibb up or down today?
Bristol Myers Squibb (BMY) moves on news, and the headlines above are the fastest way to see what is driving BMY today, from earnings, guidance and analyst moves to the broader market mood. Cross-check the reaction against the live Bristol Myers Squibb Fear and Greed Index and BMY trading volume.
What is the latest Bristol Myers Squibb news?
The newest Bristol Myers Squibb (BMY) headlines are listed above, most recent first, each linking to the original source. We pull the last 60 stories so you can scroll the full recent BMY news cycle in one place.
Where does Bristol Myers Squibb news come from?
We aggregate Bristol Myers Squibb (BMY) headlines from financial news wires and refresh them continuously. Each headline links straight to the original source.
How often is Bristol Myers Squibb news updated?
Continuously. The Bristol Myers Squibb (BMY) feed refreshes as new stories are published, so the headlines at the top are the freshest available.
How does Bristol Myers Squibb news relate to its Fear and Greed Index?
News drives sentiment, and sentiment drives price. A run of negative headlines tends to push the Bristol Myers Squibb Fear and Greed Index toward fear, positive coverage toward greed. Reading them together is how you separate noise from a real shift in mood.

Headlines are aggregated from third-party sources and link to the original publishers. CFGI does not author or endorse them.

About CFGI

The per-asset sentiment record.

CFGI is a market sentiment data company that scores crowd emotion from 0 to 100 across crypto and stock markets. Crypto readings cover the whole market and hundreds of individual assets across 15-minute, 1-hour, 4-hour and daily views. The stock index gives a live daily reading for wider stock market sentiment.

Every CFGI score is built from 10 indicators: price, volatility, volume, impulse, technical analysis, social media, dominance, search interest, whale movements and order book pressure. The same data powers our API, alerts and embeddable widgets.